For the first time, we report significant increases in the expression of GDNF brain levels after a single i.t. injection of GDNF-transfected macrophages, providing additional evidence for clinical relevance of this cell-based delivery system for PD treatment. This evidence concerns the gene GDNF and Parkinson disease.